Nicholas Butowski

Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma.

Susan Chang, Susan M. Chang, M. Prados, 2006, Neuro-oncology.

Clinical practice experience with NovoTTF-100A™ system for glioblastoma: The Patient Registry Dataset (PRiDe).

N. Butowski, J. Villano, H. Engelhard, 2014, Seminars in oncology.

Central nervous system cancers.

Henry Brem, Lawrence Recht, Mark R Gilbert, 2005, Journal of the National Comprehensive Cancer Network : JNCCN.

Central Nervous System Cancers, Version 1.2015.

Stephanie Weiss, Henry Brem, Lawrence Recht, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma

Soonmee Cha, Susan M. Chang, M. Berger, 2009, Journal of Neuro-Oncology.

Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors.

Robert Beckman, Santosh Kesari, Ian Krop, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study

Hao Xiong, Helen Wheeler, John Simes, 2017, Cancer Chemotherapy and Pharmacology.

Association of early changes in 1H MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimen

Jason C. Crane, Achuta Kadambi, Annette M. Molinaro, 2016, Neuro-oncology.

Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy

Arie Perry, Tarik Tihan, Iwei Yeh, 2016, Neuro-oncology.

ATIM-03. ACT IV: AN INTERNATIONAL, DOUBLE-BLIND, PHASE 3 TRIAL OF RINDOPEPIMUT IN NEWLY DIAGNOSED, EGFRvIII-EXPRESSING GLIOBLASTOMA

Donald M. O'Rourke, John H. Sampson, Michael Lim, 2016 .

Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab

Yan Li, Soonmee Cha, Susan M. Chang, 2016, Journal of Neuro-Oncology.